Warren Wen

1.6k total citations
47 papers, 737 citations indexed

About

Warren Wen is a scholar working on Physiology, Dermatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Warren Wen has authored 47 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 21 papers in Dermatology and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Warren Wen's work include Dermatology and Skin Diseases (21 papers), Opioid Use Disorder Treatment (18 papers) and Pain Mechanisms and Treatments (17 papers). Warren Wen is often cited by papers focused on Dermatology and Skin Diseases (21 papers), Opioid Use Disorder Treatment (18 papers) and Pain Mechanisms and Treatments (17 papers). Warren Wen collaborates with scholars based in United States, Switzerland and United Kingdom. Warren Wen's co-authors include Catherine Munera, Frédérique Menzaghi, Steven Fishbane, Steven R. Ripa, Ellie He, Aaron Yarlas, Craig Landau, K. Miller, Deborah J. Steiner and Joseph V. Pergolizzi and has published in prestigious journals such as New England Journal of Medicine, Neurology and Journal of the American Society of Nephrology.

In The Last Decade

Warren Wen

43 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Warren Wen United States	14	346	298	202	194	148	47	737
Shyamalie Jayawardena United States	12	64 0.2×	195 0.7×	19 0.1×	41 0.2×	18 0.1×	34	499
Paul Kotey United States	11	108 0.3×	94 0.3×	59 0.3×	133 0.7×	20 0.1×	17	813
Arkadiusz Derkacz Poland	13	21 0.1×	62 0.2×	26 0.1×	20 0.1×	17 0.1×	68	513
Janice L. Stumpf United States	13	22 0.1×	52 0.2×	46 0.2×	7 0.0×	20 0.1×	27	398
Roger Ellul‐Micallef Malta	15	17 0.0×	434 1.5×	13 0.1×	17 0.1×	19 0.1×	25	646
J.-P. Sauvanet France	11	77 0.2×	44 0.1×	18 0.1×	11 0.1×	5 0.0×	41	666
Cengiz Pata Türkiye	13	13 0.0×	125 0.4×	10 0.0×	6 0.0×	28 0.2×	32	598
Daniel G. Pace United States	12	13 0.0×	91 0.3×	18 0.1×	6 0.0×	12 0.1×	21	408
L. Bordier France	12	13 0.0×	149 0.5×	37 0.2×	5 0.0×	30 0.2×	95	666
Patrick Chang United States	13	14 0.0×	54 0.2×	43 0.2×	8 0.0×	5 0.0×	40	563

Countries citing papers authored by Warren Wen

Since Specialization

Citations

This map shows the geographic impact of Warren Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren Wen more than expected).

Fields of papers citing papers by Warren Wen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warren Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren Wen. The network helps show where Warren Wen may publish in the future.

Co-authorship network of co-authors of Warren Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Warren Wen. A scholar is included among the top collaborators of Warren Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warren Wen. Warren Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ständer, Sonja, Steven Fishbane, Thilo Schaufler, et al.. (2024). Chronic kidney disease–associated pruritus and quality of life with difelikefalin treatment: a post hoc analysis of phase 3 data using the Skindex-10 questionnaire. Clinical Kidney Journal. 17(10). sfae274–sfae274.

Fishbane, Steven, Deborah J. Clegg, Edgar V. Lerma, et al.. (2024). Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2. American Journal of Nephrology. 55(3). 329–333. 1 indexed citations

Weiner, Daniel E., Thilo Schaufler, Kieran McCafferty, et al.. (2023). Difelikefalin improves itch-related sleep disruption in patients undergoing haemodialysis. Nephrology Dialysis Transplantation. 39(7). 1125–1137. 5 indexed citations

Menzaghi, Frédérique, et al.. (2023). The Burden of Pruritus Associated With CKD: A Mixed Methods Analysis Among Patients Undergoing Dialysis. Kidney Medicine. 5(9). 100696–100696. 5 indexed citations

Topf, Joel Michels, Thomas D. Wooldridge, Michael Schömig, et al.. (2022). Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies. Kidney Medicine. 4(8). 100512–100512. 39 indexed citations

Fishbane, Steven, et al.. (2022). Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program. Kidney Medicine. 4(8). 100513–100513. 24 indexed citations

Weiner, Daniel E., Marc Vervloet, Sebastian Walpen, et al.. (2022). Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study. Kidney Medicine. 4(10). 100542–100542. 13 indexed citations

Weiner, Daniel E., Sebastian Walpen, Thilo Schaufler, et al.. (2021). Itch Reduction with Difelikefalin Correlates with Improved Sleep Quality in Hemodialysis Patients with Pruritus. Journal of the American Society of Nephrology. 32(10S). 28–29. 2 indexed citations

Fishbane, Steven, Deborah J. Clegg, Edgar V. Lerma, et al.. (2021). Safety and Efficacy of Difelikefalin in Black or African American Patients on Hemodialysis with CKD-Associated Pruritus: Pooled Analysis of KALM-1 and KALM-2. Journal of the American Society of Nephrology. 32(10S). 281–281. 1 indexed citations

10.

Wen, Warren, et al.. (2017). A Phase 2 Study of Nelotanserin, a Novel 5HT2A Receptor Inverse Agonist, in Dementia with Lewy Bodies and Parkinson’s Disease Dementia Subjects Experiencing Visual Hallucinations (P6.088). Neurology. 88(16_supplement). 1 indexed citations

11.

Wen, Warren, et al.. (2015). A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain. Expert Opinion on Pharmacotherapy. 16(11). 1593–1606. 28 indexed citations

12.

Kapil, Ram P., Alessandra Cipriano, Warren Wen, et al.. (2015). Pharmacokinetic Profile and Sustained 24-hour Analgesia of a Once-daily Hydrocodone Bitartrate Extended-release Tablet with Abuse-deterrent Properties. Clinical Therapeutics. 38(2). 302–314. 4 indexed citations

13.

Wen, Warren, et al.. (2015). 12-Month safety and effectiveness of once-daily hydrocodone. Journal of Opioid Management. 11(4). 339–356. 18 indexed citations

14.

Michna, Edward, et al.. (2014). Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic pain. Postgraduate Medicine. 127(1). 5–12. 10 indexed citations

15.

Miller, K., Aaron Yarlas, Warren Wen, et al.. (2014). The Impact of Buprenorphine Transdermal Delivery System on Activities of Daily Living Among Patients With Chronic Low Back Pain. Clinical Journal of Pain. 30(12). 1015–1022. 10 indexed citations

16.

Yarlas, Aaron, et al.. (2013). Responsiveness among patient-reported measures of quality of life, quality of sleep, and functional disability to pain and impact of buprenorphine transdermal system (BTDS) treatment in chronic low back pain patients. Value in Health. 16(3). A122–A122. 1 indexed citations

17.

Yarlas, Aaron, et al.. (2012). PSY6 The Impact on Sleep Quality of Butrans® (Buprenorphine) Transdermal System 5 Mcg/Hour (BTDS 5) and 20 Mcg/Hour (BTDS 20) Dosages in Patients With Moderate-to-Severe Chronic Low Back Pain. Value in Health. 15(4). A99–A99. 1 indexed citations

18.

Ripa, Steven R., Bill McCarberg, Catherine Munera, Warren Wen, & Craig Landau. (2012). A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain. Expert Opinion on Pharmacotherapy. 13(9). 1229–1241. 11 indexed citations

19.

Yarlas, Aaron, K. Miller, Warren Wen, et al.. (2012). A Randomized, Placebo-Controlled Study of the Impact of the 7-Day Buprenorphine Transdermal System on Health-Related Quality of Life in Opioid-Naïve Patients With Moderate-to-Severe Chronic Low Back Pain. Journal of Pain. 14(1). 14–23. 28 indexed citations

20.

Steiner, Deborah J., et al.. (2011). Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid-Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched, Randomized, Double-Blind, Placebo-Controlled Study. Journal of Pain and Symptom Management. 42(6). 903–917. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact